Tag: Bristol Myers Squibb
Bristol Myers leads $237M round into Pathos AI platform
Pathos AI closed a $237M Series E led by Bristol Myers Squibb at a $3B valuation, adding Alzheimer's work to…
Chai Discovery scores BMS pact for AI-built antibodies
Chai Discovery adds Bristol Myers Squibb to its pharma roster for AI-built therapeutic antibodies.
Bristol Myers Squibb partners with Nvidia on AI factory for drug discovery
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug discovery.